share_log

Evofem Biosciences On August 9, Received Written Notice From Nasdaq That It Has Determined To Delist Co.'s Securities From Nasdaq Capital Market; Nasdaq Will Suspend Trading In Company's Securities Effective At Open Of Business On August 11, 2022

Evofem Biosciences On August 9, Received Written Notice From Nasdaq That It Has Determined To Delist Co.'s Securities From Nasdaq Capital Market; Nasdaq Will Suspend Trading In Company's Securities Effective At Open Of Business On August 11, 2022

Evofem 生物科學 8 月 9 日,從納斯達克收到書面通知,它已決定撤銷有限公司。」納斯達克資本市場的證券;納斯達克將於 2022 年 8 月 11 日開始營業時暫停公司證券交易
Benzinga Real-time News ·  2022/08/10 21:00

Evofem Biosciences On August 9, Received Written Notice From Nasdaq That It Has Determined To Delist Co.'s Securities From Nasdaq Capital Market; Nasdaq Will Suspend Trading In Company's Securities Effective At Open Of Business On August 11, 2022

Evofem 生物科學 8 月 9 日,從納斯達克收到書面通知,它已決定撤銷有限公司。」納斯達克資本市場的證券;納斯達克將於 2022 年 8 月 11 日開始營業時暫停公司證券交易

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論